NEKTAR THERAPEUTICS financial data

Symbol
NKTR on Nasdaq
Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 368% % -25%
Quick Ratio 13% % -62%
Debt-to-equity 536% % 64%
Return On Equity -399% % -165%
Return On Assets -63% % -78%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28,687,963 shares -85%
Common Stock, Shares, Outstanding 20,378,832 shares 65%
Entity Public Float $318,000,000 USD 41%
Common Stock, Value, Issued $2,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 16,870,930 shares 23%
Weighted Average Number of Shares Outstanding, Diluted 16,870,930 shares 23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $55,232,000 USD -44%
Research and Development Expense $117,330,000 USD -3%
General and Administrative Expense $68,673,000 USD -11%
Costs and Expenses $195,334,000 USD -4.1%
Operating Income (Loss) $140,102,000 USD -33%
Nonoperating Income (Expense) $15,385,000 USD -9.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $119,200,000 USD 57%
Income Tax Expense (Benefit) $138,000 USD 42%
Net Income (Loss) Attributable to Parent $164,076,000 USD -38%
Earnings Per Share, Basic -9.73 USD/shares -12%
Earnings Per Share, Diluted -9.73 USD/shares -12%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $15,116,000 USD -66%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD -100%
Inventory, Net $0 USD
Other Assets, Current $20,514,000 USD 238%
Assets, Current $266,266,000 USD 1.9%
Property, Plant and Equipment, Net $2,060,000 USD -40%
Operating Lease, Right-of-Use Asset $2,941,000 USD -65%
Other Assets, Noncurrent $5,648,000 USD 22%
Assets $280,406,000 USD -7.7%
Accounts Payable, Current $10,770,000 USD -6.8%
Employee-related Liabilities, Current $2,940,000 USD 3.8%
Accrued Liabilities, Current $22,271,000 USD -26%
Liabilities, Current $53,536,000 USD -13%
Operating Lease, Liability, Noncurrent $65,256,000 USD -21%
Other Liabilities, Noncurrent $8,625,000 USD 19%
Liabilities $190,574,000 USD -22%
Accumulated Other Comprehensive Income (Loss), Net of Tax $17,000 USD -72%
Retained Earnings (Accumulated Deficit) $3,760,286,000 USD -4.6%
Stockholders' Equity Attributable to Parent $89,832,000 USD 48%
Liabilities and Equity $280,406,000 USD -7.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $49,053,000 USD -2.4%
Net Cash Provided by (Used in) Financing Activities $42,003,000 USD
Net Cash Provided by (Used in) Investing Activities $43,689,000 USD 127%
Common Stock, Shares Authorized 390,000,000 shares 30%
Common Stock, Shares, Issued 20,378,832 shares 58%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,358,000 USD -140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,116,000 USD -66%
Deferred Tax Assets, Valuation Allowance $892,432,000 USD 3.9%
Deferred Tax Assets, Gross $893,482,000 USD 3.6%
Operating Lease, Liability $85,751,000 USD -16%
Payments to Acquire Property, Plant, and Equipment $157,000 USD -64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $164,120,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid $96,508,000 USD -19%
Operating Lease, Liability, Current $20,495,000 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $23,682,000 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $21,096,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.058 pure 0%
Deferred Income Tax Expense (Benefit) $38,000 USD 98%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,757,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three $24,427,000 USD 3.1%
Deferred Tax Assets, Operating Loss Carryforwards $625,497,000 USD 6.5%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $135,935,000 USD 0.19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $25,195,000 USD 3.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,050,000 USD -69%
Share-based Payment Arrangement, Expense $12,649,000 USD -41%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%